[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA05001451A - Procesos para preparar nucleosidos de 1,3-dioxolano. - Google Patents

Procesos para preparar nucleosidos de 1,3-dioxolano.

Info

Publication number
MXPA05001451A
MXPA05001451A MXPA05001451A MXPA05001451A MXPA05001451A MX PA05001451 A MXPA05001451 A MX PA05001451A MX PA05001451 A MXPA05001451 A MX PA05001451A MX PA05001451 A MXPA05001451 A MX PA05001451A MX PA05001451 A MXPA05001451 A MX PA05001451A
Authority
MX
Mexico
Prior art keywords
preparing
processes
dioxolane nucleosides
nucleosides
dioxolane
Prior art date
Application number
MXPA05001451A
Other languages
English (en)
Inventor
Jinfa Du
Original Assignee
Pharmasset Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Ltd filed Critical Pharmasset Ltd
Publication of MXPA05001451A publication Critical patent/MXPA05001451A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/20—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen nuevos procesos para preparar nucleosidos de 1,3-dioxolano de Formulas Generales (1) y (II): en donde B es una purina o pirimidina base o un analogo o derivado de las mismas. La invencion tambien proporciona intermediarios para uso en la preparacion de estos compuestos: (Ver Formula).
MXPA05001451A 2002-08-06 2003-08-06 Procesos para preparar nucleosidos de 1,3-dioxolano. MXPA05001451A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40165502P 2002-08-06 2002-08-06
PCT/US2003/024986 WO2004028445A2 (en) 2002-08-06 2003-08-06 Processes for preparing 1,3-dioxolane nucleosides

Publications (1)

Publication Number Publication Date
MXPA05001451A true MXPA05001451A (es) 2005-09-30

Family

ID=32043165

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05001451A MXPA05001451A (es) 2002-08-06 2003-08-06 Procesos para preparar nucleosidos de 1,3-dioxolano.

Country Status (14)

Country Link
US (1) US6855821B2 (es)
EP (1) EP1534255B1 (es)
JP (1) JP4560407B2 (es)
KR (1) KR101108115B1 (es)
AT (1) ATE496054T1 (es)
AU (1) AU2003294212B2 (es)
BR (1) BR0313302A (es)
CA (1) CA2494183C (es)
DE (1) DE60335805D1 (es)
ES (1) ES2360096T3 (es)
HK (1) HK1078781A1 (es)
IL (2) IL166682A0 (es)
MX (1) MXPA05001451A (es)
WO (1) WO2004028445A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296360A1 (en) * 2002-12-09 2004-06-30 Emory University Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv
CA2733842A1 (en) 2003-05-30 2005-01-13 Pharmasset, Inc. Modified fluorinated nucleoside analogues
US7785839B2 (en) 2004-02-03 2010-08-31 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7956087B2 (en) * 2005-04-21 2011-06-07 Kao Corporation Cosmetic composition for skin and wrinkle improver
JP2011513398A (ja) * 2008-03-03 2011-04-28 スティーフェル ラボラトリーズ インコーポレイテッド 鏡像異性的に純粋なジオールおよびジオキソラン化合物の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028519A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Substituierte 2,5,7-trioxan-bicyclo (2.2.2) octan-6-one und 3,6,8-trioxa-bicyclo (3.2.1) octan-4-one und verfahren zu deren herstellung
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
IT1244501B (it) 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9525606D0 (en) 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
IT1301977B1 (it) * 1998-07-31 2000-07-20 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di r-(-)-carnitina
CA2340214C (en) 1998-08-12 2007-10-30 Triangle Pharmaceuticals, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
DK1140937T3 (da) 1998-12-23 2004-03-22 Shire Biochem Inc Antivirale nucleosid-analoger

Also Published As

Publication number Publication date
EP1534255A2 (en) 2005-06-01
CA2494183C (en) 2012-01-03
WO2004028445A2 (en) 2004-04-08
AU2003294212B2 (en) 2010-01-07
BR0313302A (pt) 2005-06-28
ATE496054T1 (de) 2011-02-15
JP2006504703A (ja) 2006-02-09
DE60335805D1 (de) 2011-03-03
JP4560407B2 (ja) 2010-10-13
IL166682A0 (en) 2006-01-15
WO2004028445A3 (en) 2004-06-10
US6855821B2 (en) 2005-02-15
KR101108115B1 (ko) 2012-01-31
ES2360096T3 (es) 2011-05-31
IL166682A (en) 2011-06-30
EP1534255B1 (en) 2011-01-19
HK1078781A1 (en) 2006-03-24
AU2003294212A1 (en) 2004-04-19
EP1534255A4 (en) 2006-10-18
CA2494183A1 (en) 2004-04-08
KR20050052461A (ko) 2005-06-02
US20040087806A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
WO2002098865A3 (fr) Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
HK1053122A1 (en) Pyrimidine compounds and their use in the preparation of a triazolo-pyrimidine carba nucleoside
WO2002102313A3 (en) Pyrimidine inhibitors of phosphodiesterase (pde) 7
WO2003015798A1 (en) Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
IL163781A0 (en) Purine derivatives as kinase inhibitors
ATE254132T1 (de) Antivirale pyrimidin nucleoside derivate
ATE134644T1 (de) Weitere antivirale pyrimidin-nukleosiden
HK1088013A1 (en) Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
AU2003248647A8 (en) Stereoselective synthesis of 1,2-disubstituted cycloalkyls
WO2003002580A8 (en) 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
IL138288A0 (en) Process for the production of purine derivatives and intermediates thereof
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MXPA05001451A (es) Procesos para preparar nucleosidos de 1,3-dioxolano.
MXPA04005151A (es) Compuestos terapeuticos.
MY127470A (en) Process for the synthesis of chloropurine intermediates
EP1613606A4 (en) PROCESS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES
AU2003276009A1 (en) Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c
WO2004039808A3 (en) Process for the preparation of ganciclovir
WO2003033498A3 (en) A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine
SG145574A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
MXPA05009152A (es) Preparacion de k-252a.
HK1090046A1 (en) Tetrahydro-4h-pyrido [1, 2-a]pyrimidines and related compounds useful as hiv integrase inhibitors

Legal Events

Date Code Title Description
FG Grant or registration
HH Correction or change in general